Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

T2 Biosystms Inc (TTOO)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow T2 Biosystms Inc's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.7550 +0.0350    +1.29%
24/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
2.6000
-0.1550
-5.6261%
4:09:30 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 323,681
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 2.6000 - 2.7800
T2 Biosystms Inc 2.7550 +0.0350 +1.29%

T2 Biosystms Inc Company Profile

 
Get an in-depth profile of T2 Biosystms Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

113

Equity Type

ORD

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Contact Information

Address 101 Hartwell Avenue
Lexington, 02421
United States
Phone 781 761 4646
Fax 781 240 0464
Web www.t2biosystems.com

Top Executives

Name Age Since Title
John J. Sperzel 60 2020 President, CEO & Chairman
Peter G. Pappas - 2011 Member of Clinical Advisory Board
Louis B. Rice - 2011 Member of Clinical Advisory Board
Seymour E. Liebman 73 2016 Independent Director
John W. Cumming 78 2014 Lead Independent Director
David B. Elsbree 75 2014 Independent Director
Eric S. Rosenberg - 2011 Member of Clinical Advisory Board
Michael A. Pfaller 72 2014 Member of Clinical Advisory Board
Robin Toft 62 2020 Independent Director
Ninfa M. Saunders 72 2020 Independent Director
Sean X. Zhang - 2022 Member of Scientific Advisory Board
George Pankey - 2022 Member of Scientific Advisory Board
Laura Lee Adams 67 2021 Independent Director
Denise L. Uettwiller-Geiger - 2022 Member of Scientific Advisory Board
M. Hong Nguyen - 2022 Member of Scientific Advisory Board
Thomas J. Walsh - 2022 Member of Scientific Advisory Board
Michael J. Rybak - 2022 Member of Scientific Advisory Board
Randall T. Hayden - 2022 Member of Scientific Advisory Board
James W. Snyder - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

TTOO Comments

Write your thoughts about T2 Biosystms Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Claus Østerballe
Claus Østerballe Nov 10, 2023 11:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This stock haven raise since it split?..he he..Manipulation stock! Dont buy it
Reply
1 0
Report
Jeremy Glaser
Jeremy Glaser Nov 10, 2023 11:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
getting delisted junk
Reply
0 0
Report
AI Kanak
AIKanak Oct 13, 2023 6:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Reddit and Robinhood have made TTOO a meme stock. Its price may go up just once or twice befoe if sinks like a broken Titanic.
Reply
4 1
Report
AI Kanak
AIKanak Oct 13, 2023 5:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
FDA news is just to distract investors. The company has no money to work on projects even after FDA approval. The MULN story is being repeated here. CRKN is another stock treading this path soon, beware!
Reply
0 0
Report
Gene Foley
Gene Foley Oct 13, 2023 5:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cant this issue stock? I thought that was approved by shareholders
Reply
0 0
Report
AI Kanak
AIKanak Oct 13, 2023 5:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It will dilute the stock number, meaning the price will plummet like a nose dive.
Reply
0 0
Report
Claus Østerballe
Claus Østerballe Oct 13, 2023 9:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Manipulation stock…
Reply
1 0
Report
Ahmad Rasheed
Ahmad Rasheed Oct 13, 2023 6:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
For God sake, why people are selling their stock for 50% less?!
Reply
0 0
Report
Jason Maksamakkara
Jason Maksamakkara Oct 13, 2023 6:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Because of short temper and stupidity
Reply
1 0
Report
Billy Joens
Billy Joens Sep 29, 2023 12:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Retest of 28/.30
Reply
2 0
Report
Jeremy Glaser
Jeremy Glaser Sep 29, 2023 12:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
junk stock 1 100 joke
Reply
0 0
Report
Stephen Kotski
Stephen Kotski Sep 20, 2023 12:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Let’s hope news will be released AH going forward to amplify short covering
Reply
3 0
Report
Jeremy Glaser
Jeremy Glaser Sep 20, 2023 12:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
stock being shorted heavily same as muln stock stealing hard earned money corrupt.
Reply
0 0
Report
Chousein Kozar
Chousein Kozar Sep 20, 2023 12:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Longterm price finds its way. Let them short it, wait for the spring to be fully pushed and then watch the stock at 5$
Reply
1 0
Report
Ahmad Rasheed
Ahmad Rasheed Sep 20, 2023 12:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Chousein Kozar can it do it?
Reply
0 0
Report
Stephen Kotski
Stephen Kotski Sep 20, 2023 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Spike upwards on the way most likely with a pleather of news ?
Reply
2 0
Report
Basel haddadin
Basel haddadin Aug 23, 2023 11:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
moving up
Reply
6 0
Report
Gerald Braffet
Gerald Braffet Aug 20, 2023 7:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think theres a good chance this will run tomorrow or this week. Lots and lots of buzz. Opinion and not financial advice
Reply
4 0
Report
Gerald Braffet
Gerald Braffet Aug 20, 2023 7:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I hope not. I really want this to happen.
Reply
1 0
Report
Basel haddadin
Basel haddadin Aug 20, 2023 7:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
she doesn't know anything, ignor her
Reply
2 0
Report
Gerald Braffet
Gerald Braffet Aug 20, 2023 7:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sylvia Doloff show us some pictures then.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email